Related Experiment Video
Updated: Jan 23, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Published on: April 15, 2014
Pro-inflammatory Effect of Downregulated CD73 Expression in EAE Astrocytes
Shumin Zhou1, Guoping Liu2, Jie Guo2
1Clinical Laboratory, The 2nd Hospital of Tianjin Medical University, Tianjin, China.
In experimental autoimmune uveitis, astrocytes lose CD73, reducing adenosine and promoting inflammation. This CD73 downregulation on astrocytes exacerbates disease severity.
Area of Science:
- Neuroimmunology
- Immunology
- Cell Biology
Background:
- CD73 (Cluster of Differentiation 73) is an ectonucleotidase crucial for regulating immune responses through adenosine production.
- Adenosine, a product of CD73 activity, generally exerts anti-inflammatory effects within the central nervous system (CNS).
- Experimental Autoimmune Uveitis (EAU) is an inflammatory disease model involving immune cell infiltration and activation within the eye and CNS.
Purpose of the Study:
- To investigate alterations in CD73 expression, localization, and activity in brain cells, particularly neuroglia, during EAU.
- To determine if changes in CD73 on brain cells influence the activation of effector T cells.
- To elucidate the role of astrocyte CD73 in the pathogenesis of EAU.
Main Methods:
- Flow cytometry was used to quantify membrane-bound CD73 on various brain cell types from naïve and EAU-induced mice.
- Wild-type and CD73-deficient (CD73-/-) astrocytes were utilized to assess CD73's impact on astrocyte function and T cell activation.
- Experiments involved manipulating extracellular adenosine levels and using CD73 inhibitors or adenosine receptor antagonists.
Main Results:
- A significant decrease in membrane-bound CD73 was observed in astrocytes from EAU-induced mice compared to controls.
- CD73 deficiency in astrocytes impaired their ability to be modulated by extracellular AMP, while adenosine could still inhibit their function.
- Interaction with CD4+ T cells led to CD73 downregulation on astrocytes in EAU models, correlating with disease progression.
Conclusions:
- Astrocytes downregulate CD73 during EAU, likely due to interactions with infiltrating CD4+ T cells.
- This CD73 loss on astrocytes reduces local adenosine generation, diminishing its anti-inflammatory effects.
- The downregulation of CD73 in astrocytes represents a pro-inflammatory mechanism that facilitates EAU pathogenesis.
More Related Videos
10:42Determining Cell-surface Expression and Endocytic Rate of Proteins in Primary Astrocyte Cultures Using Biotinylation
Published on: July 3, 2017
11:19Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
Published on: September 26, 2015
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: